Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study
- Posted on November 6, 2025
- By CNBC
- 3 Views
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study
The highest dose of Eli Lilly's weekly injection helped patients with obesity or who are overweight lose 20.1% of their body weight on average at 48 weeks.
